Cardiovascular disease continues to rise across West Africa, silently displacing infectious diseases as a leading cause of death. The World Health Organization’s regional estimates up to 2021 indicate that hypertension affects between 27 and 46 percent of adults in West Africa. Many are unaware of their condition until complications such as stroke, heart failure, or kidney damage occur. Weak screening systems, delayed diagnosis, and gaps in patient education compound the challenge. Yet embedded within the region’s health systems is a largely underutilized force with the capability to shift outcomes: pharmacists.
As a pharmacist specialist trained through the West African Postgraduate College of Pharmacists and through years of professional engagement in Nigeria’s pharmaceutical and clinical environment, I have seen first-hand how pharmacists influence population health. During my tenure with Novartis, where I supported cardio renal brands and led large-scale clinician education programs, it became clear that pharmacists are positioned to accelerate earlier detection of cardiovascular conditions and strengthen patient understanding of chronic disease management. This article highlights the strategic role pharmacists can play, the progress made so far, and the policy actions required for sustainable improvement.
The growing cardiovascular burden in West Africa
Non-communicable diseases have steadily increased across the region during the last decade, driven by urbanization, changing diets, socioeconomic pressure, and limited access to preventive services. In Nigeria, studies published between 2018 and 2021 showed that only a minority of hypertensive patients achieve adequate blood pressure control. Late presentation remains a common pattern. A significant proportion of patients first encounter the health system only after complications have developed.
The challenge is not solely clinical. Health seeking behavior is often reactive rather than preventive. Community-level knowledge about cardiovascular risk factors is low. Meanwhile, many primary healthcare centers remain under resourced and overstretched. This combination of systemic gaps creates an environment where cardiovascular disease spreads quietly, often undetected until severe.
Pharmacists as a frontline resource for early detection
Across West Africa, pharmacies are one of the most accessible health facilities. They serve populations in both urban and rural areas, often acting as the first point of contact for individuals seeking health advice. This proximity creates an opportunity for structured hypertension and cardiovascular risk screening.
During my work as a clinical pharmacist and later as a medical sales professional supporting large treatment centers, I observed that routine pharmacist led screenings consistently revealed undiagnosed hypertension and uncontrolled blood pressure levels among walk in clients. Even basic interventions such as blood pressure checks, lifestyle counselling, and medication review changed the trajectory of many patients. Community pharmacists can significantly reduce the delay between disease onset and diagnosis when equipped with validated tools and protocols.
Several countries within the region had begun pilot programs by 2020 that integrated pharmacist led screening into broader non communicable disease strategies. Nigeria’s National Multisectoral Action Plan for Non Communicable Diseases (2019 to 2025) recognizes the need for expanded screening across multiple health cadres. Pharmacists fit naturally within this framework because they combine clinical knowledge with accessibility.
Enhancing physician engagement through pharmacist led data insights
One of the most valuable lessons from my experience with Novartis was the impact of real time data collection on improving physician awareness. Coordinating the cardio renal team required gathering feedback from clinicians, documenting patient response patterns, and identifying educational needs. The insights helped us align brand messages with clinical realities and supported physicians in optimizing treatment.
This approach is equally powerful in the context of public health. When pharmacists regularly document screening outcomes and share trends with physicians and health authorities, the value chain becomes more responsive. For example, recurring detection of uncontrolled hypertension within a specific district can guide local clinicians to adjust outreach efforts or request additional diagnostic support. Data informed engagement fosters collaboration between pharmacists and physicians and contributes to more cohesive cardiovascular care.
Patient education: Where pharmacists create transformational change
African health systems face a persistent challenge in patient education. Chronic disease management depends heavily on behavior change, yet many patients struggle to adhere to long term medication regimens. Poor understanding of dosing, fear of side effects, and cultural beliefs often undermine adherence.
Pharmacists fill this gap because they interact directly with patients at the point of dispensing. During my practice, I noticed that simple interventions such as explaining the purpose of each medication, clarifying expectations, and outlining early warning signs significantly improved patient confidence. At Novartis, conducting specialist targeted symposiums reinforced this through structured updates and evidence based teaching.
Across West Africa, pharmacists can deliver high quality patient education that supports early detection, adherence, and health system sustainability. When pharmacy teams adopt standardized counselling techniques and monitoring tools, patients gain the confidence to take responsibility for their health.
The role of professional training and regional institutions
The West African Postgraduate College of Pharmacists has long emphasized advanced competency in pharmaceutical care. Programs designed by the College provide pharmacists with the skills required for chronic disease management, rational drug therapy, and community health leadership. These competencies align directly with the demands of cardiovascular care.
Pharmacists who undergo specialized training are better equipped to interpret clinical guidelines, engage with multidisciplinary teams, and counsel patients with complex needs. Strengthening postgraduate training pathways across West Africa will ensure that pharmacists contribute more effectively to early detection and long term management of cardiovascular disease.
Policy opportunities to advance pharmacist led cardiovascular care
Achieving meaningful impact requires a well supported policy environment. Several steps are essential.
• Integrate pharmacists into national non communicable disease screening strategies: Pharmacies should be formally recognized as screening centers for hypertension and other cardiovascular risk factors. Clear protocols, standard recording templates, and referral pathways must be established through ministries of health.
• Expand continuing professional development in cardiovascular care: Training should be supported through government and professional bodies. Pharmacists need continuous exposure to clinical updates, treatment guidelines, and communication techniques.
• Strengthen data reporting and referral systems: Digital tools that allow pharmacists to record and share screening results with primary care centers can enhance coordination and reduce patient loss to follow up.
• Encourage public private partnerships: Large pharmaceutical organizations demonstrated during the last decade that structured educational programs can improve clinical decision making. Collaboration between the public sector, professional bodies, and industry partners can support pharmacist led initiatives without compromising ethical standards.
• Support community education campaigns: Public health communication strategies should use pharmacists as community educators. Campaigns on salt reduction, physical activity, smoking cessation, and medication adherence become more effective when pharmacists reinforce them at point of care.
Looking ahead: A strategic window for strengthening West Africa’s health systems
Cardiovascular disease will remain a defining health challenge in West Africa unless early detection and patient engagement improve significantly. Pharmacists have the reach, expertise, and community trust required to transform outcomes, yet their potential remains underutilized.
My experiences across clinical, community, and industry settings have shown that pharmacists influence not only access to medicines but also the behaviors and decisions that shape long term health. Empowering pharmacists will create earlier diagnosis, stronger health literacy, better collaboration across disciplines, and a more resilient health system.
As cardiovascular disease continues to rise, the region cannot afford to overlook a health workforce that is positioned at the heart of communities. Strengthening pharmacist led care is not simply an operational adjustment. It is a strategic investment in the future of West Africa’s public health.
